NeuroOne Medical Technologies(NMTC)
$0.80+0.03 (+3.22%)
NMTC
NeuroOne Medical Technologies financials statements
$0.80
At close:+0.03 (+3.22%)
Want to see NMTC full AI Analyst Report?
NeuroOne Medical Technologies (NMTC) Ratios
203 Followers
NeuroOne Medical Technologies Ratios
NMTC's free cash flow for Q3 2026 was $-1.10M. For the 2026 fiscal year, NMTC's free cash flow was decreased by $-19.66K and operating cash flow was $-1.08M. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.44 | 2.09 | 4.08 | 3.93 | 6.17 |
| Quick Ratio | 3.47 | 0.90 | 3.12 | 3.70 | 6.09 |
| Cash Ratio | 2.85 | 0.66 | 2.97 | 2.63 | 5.84 |
| Solvency Ratio | -0.90 | -2.65 | -6.31 | -3.07 | -7.08 |
| Operating Cash Flow Ratio | -1.23 | -4.98 | -7.19 | -2.43 | -7.28 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 6.51M | $ 83.00K | $ 5.47M | $ 8.96M | $ 5.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.02 | 0.02 | 0.04 |
| Debt-to-Equity Ratio | 0.04 | 0.32 | 0.03 | 0.02 | 0.05 |
| Debt-to-Capital Ratio | 0.04 | 0.24 | 0.03 | 0.02 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.53 | 6.53 | 1.30 | 1.34 | 1.21 |
| Debt Service Coverage Ratio | -9.01 | -51.72 | 0.00 | 0.00 | -3209.30 |
| Interest Coverage Ratio | -12.65 | -51.91 | 0.00 | 0.00 | -3346.94 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.09 | 0.02 | 0.01 | 0.01 | 0.03 |
| Net Debt to EBITDA | 2.09 | 0.10 | 0.44 | 0.80 | 0.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.30% | 31.27% | 23.38% | -41.36% | -54.87% |
| EBIT Margin | -27.04% | -350.10% | -612.32% | -5860.15% | -5582.56% |
| EBITDA Margin | -24.88% | -342.96% | -602.12% | -5790.85% | -5499.97% |
| Operating Profit Margin | -34.94% | -344.26% | -612.32% | -5860.15% | -5735.86% |
| Pretax Profit Margin | -29.80% | -356.74% | -607.42% | -5841.95% | -5584.28% |
| Net Profit Margin | -29.80% | -356.74% | -607.42% | -5841.95% | -5584.28% |
| Continuous Operations Profit Margin | -29.80% | -356.74% | -607.42% | -5841.95% | -5584.28% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 85.30% | 103.62% | 99.20% | 99.69% | 97.36% |
| Return on Assets (ROA) | -33.43% | -229.39% | -146.46% | -77.98% | -125.32% |
| Return on Equity (ROE) | -50.98% | -1498.53% | -189.77% | -104.12% | -151.79% |
| Return on Capital Employed (ROCE) | -49.83% | -376.57% | -189.62% | -103.16% | -151.23% |
| Return on Invested Capital (ROIC) | -49.11% | -368.88% | -185.82% | -102.28% | -148.75% |
| Return on Tangible Assets | -33.57% | -232.30% | -148.10% | -78.67% | -127.47% |
| Earnings Yield | -10.11% | -46.49% | -73.50% | -36.98% | -23.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.56 | 19.55 | 0.00 | 5.15 | 3.69 |
| Payables Turnover | 3.92 | 2.31 | 2.18 | 0.26 | 0.52 |
| Inventory Turnover | 1.78 | 0.90 | 0.87 | 0.34 | 2.81 |
| Fixed Asset Turnover | 23.52 | 5.14 | 2.81 | 0.32 | 0.35 |
| Asset Turnover | 1.12 | 0.64 | 0.24 | 0.01 | 0.02 |
| Working Capital Turnover Ratio | 2.34 | 0.87 | 0.27 | 0.02 | 0.05 |
| Cash Conversion Cycle | 150.39 | 265.65 | 254.14 | -265.71 | -470.56 |
| Days of Sales Outstanding | 38.16 | 18.67 | 0.00 | 70.87 | 99.03 |
| Days of Inventory Outstanding | 205.44 | 405.27 | 421.31 | 1062.79 | 130.03 |
| Days of Payables Outstanding | 93.21 | 158.28 | 167.16 | 1399.37 | 699.62 |
| Operating Cycle | 243.60 | 423.94 | 421.31 | 1133.67 | 229.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.42 | -0.41 | -0.71 | -0.47 | -0.80 |
| Free Cash Flow Per Share | -0.44 | -0.42 | -0.73 | -0.49 | -0.81 |
| Dividend Paid and CapEx Coverage Ratio | -34.71 | -91.61 | -33.55 | -27.32 | -128.25 |
| Capital Expenditure Coverage Ratio | -34.71 | -91.61 | -33.55 | -27.32 | -128.25 |
| Operating Cash Flow Coverage Ratio | -10.63 | -42.33 | -69.89 | -37.06 | -27.25 |
| Operating Cash Flow to Sales Ratio | -0.23 | -3.19 | -6.60 | -43.93 | -48.29 |
| Free Cash Flow Yield | -8.18% | -42.02% | -82.25% | -28.83% | -20.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.87 | -2.15 | -1.36 | -2.70 | -4.25 |
| Price-to-Sales (P/S) Ratio | 2.95 | 7.67 | 8.26 | 157.96 | 237.18 |
| Price-to-Book (P/B) Ratio | 5.04 | 32.23 | 2.58 | 2.82 | 6.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.22 | -2.38 | -1.22 | -3.47 | -4.87 |
| Price-to-Operating Cash Flow Ratio | -12.57 | -2.41 | -1.25 | -3.60 | -4.91 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | 0.07 | -0.43 | 0.08 | 0.07 |
| Enterprise Value Multiple | -9.76 | -2.14 | -0.94 | -1.92 | -3.64 |
| Enterprise Value | 29.37M | 25.29M | 11.00M | 19.08M | 35.67M |
| EV to EBITDA | -9.76 | -2.14 | -0.94 | -1.92 | -3.64 |
| EV to Sales | 2.43 | 7.33 | 5.63 | 111.47 | 200.21 |
| EV to Free Cash Flow | -10.06 | -2.27 | -0.83 | -2.45 | -4.11 |
| EV to Operating Cash Flow | -10.35 | -2.30 | -0.85 | -2.54 | -4.15 |
| Tangible Book Value Per Share | 1.05 | 0.03 | 0.34 | 0.59 | 0.60 |
| Shareholders’ Equity Per Share | 1.06 | 0.03 | 0.34 | 0.60 | 0.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.81 | 0.13 | 0.11 | 0.01 | 0.02 |
| Net Income Per Share | -0.54 | -0.46 | -0.65 | -0.63 | -0.93 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.10 | 1.02 | 0.99 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.41 | 1.47 | 3.55 | 28.80 | 22.03 |
| SG&A to Revenue | 0.61 | 2.29 | 3.46 | 39.19 | 33.24 |
| Stock-Based Compensation to Revenue | 0.10 | 0.39 | 0.57 | 5.53 | 10.07 |
| Income Quality | 0.79 | 0.89 | 1.09 | 0.75 | 0.86 |
Currency in USD
